Granules India Q2 profit rises nearly 40% as sales offset costs
The Indian drugmaker reported a nearly 40% increase in second-quarter profit, with new product launches and strong overseas sales of its main medicines outweighing higher production costs.
Indian drugmaker Granules India NSE:GRANULES reported a second-quarter profit rise of nearly 40% on Monday, as new product launches and strong sales of its main medicines in key overseas markets outweighed higher production costs.Consolidated net profit for the quarter ended September 30 rose to 1…